Washington DC
,
USA
21 - 25 June 2025
The congress symposium is no longer available
International Society on Thrombosis and Haemostasis (ISTH 2025)
Presentation materials
Saturday, 21 June 2025
ORAL PRESENTATION
Mim8 enhances procoagulant activity of select hemophilia B-causing factor IX variants
Sebastian Leyes Porello1; Kyumin Lee1; Jacob Lund3; Benjamin Samelson-Jones1,2
MATERIALS AVAILABLE
Sunday, 22 June 2025
ORAL PRESENTATION
FRONTIER5 direct switch study: Safety of initiating Mim8 prophylaxis without washout of Emicizumab
Johannes Oldenburg1*; Gary Benson2; Pratima Chowdary3; Robert Klamroth4,5; Anne Lienhart6; Davide Matino7; Camila Martins Mazini Tavares8 Keiji Nogami9 Flora Peyvandi10,11; Amalie Rhode Høgh Nielsen8; Guy Young12; Allison P Wheeler13
MATERIALS AVAILABLE
Monday, 23 June 2025
POSTER
Non-joint bleeds in patients with hemophilia A or B with inhibitors: Concizumab explorer7 study
Amy Shapiro1;Ana Boban2; Renée Brown Frandsen3; Giancarlo Castaman4; Kingsley Hampton5; Keiji Nogami6; Jameela Sathar7; Senthil Vel3; Jerzy Windyga8; Victor Jimenez Yuste9
MATERIALS AVAILABLE
POSTER
Evaluating pen-injector handling and PROs in patients switching from emicizumab to Mim8 in FRONTIER5
Johnny Mahlangu1; Sanjay Ahuja2; Erin Cockrell3; Víctor Jiménez-Yuste4; Michele Schiavulli5; Amalie Rhode Høgh Nielsen6; Camila Martins Mazini Tavares6; Cédric Hermans7
MATERIALS AVAILABLE
ORAL PRESENTATION
In vitro activity of Inno8 in global hemostatic assays alone and with other hemostatic agents.
Jacob Lund1; Kasper Jensen2; Mirella Ezban1
MATERIALS AVAILABLE
Tuesday, 24 June 2025
ORAL PRESENTATION
Genomic integration of FVIII transgene in hepatocytes restores durable FVIII activity in vivo
Jacob Lund1; John Moore2; Carsten Dan Ley1; Karl Agger2; Christopher William Smith1; Jesper Tranekær Jørgensen1; Michelle Scalley Kim2; Jazz Hallinan2; Kendall Sanson2; Rikke Hvid Lindecrona1; Lene Diness Jensen1; Nadin Jahnke2; Gert Bolt3; Erin Louise Brown2; Jonas Ahnfelt-Rønne1; Esther Bloem3; Jonas Højfeldt2; Karina Thorn2 and Gro Klitgaard Povlsen1
MATERIALS AVAILABLE
POSTER
Joint bleed diagnosis and treatment delays in people with hemophilia: Global real-world data
Flora Peyvandi1; Neil Reynolds2; Olivera Rajkovic-Hooley2;Cléa Percier3; Leonardo Gottlob3; Roberta Gualtierotti1
MATERIALS AVAILABLE
POSTER
US physician-reported prophylactic treatment satisfaction and joint health of people with hemophilia
lnara Fazio-Eynullayeva1; Cléa Percier2; Nathan Ball3; Kieran WynneCattanach3
MATERIALS AVAILABLE
POSTER
The effect of Concizumab on thrombin generation in FVII deficient plasma
Marianne Kjalke1
MATERIALS AVAILABLE
ORAL PRESENTATION
Annualized bleeding rates in hemophilia A/B and target joints: Concizumab explorer8 study
Allison P Wheeler1; Pantep Angchaisuksiri2; Shashikant Apte3; Gary Benson4; Renée Brown Frandsen5; Anthony KC Chan6; Hermann Eichler7; Teruhisa Fujii8; Mohamed Salim Nekkal9; Sonata Šaulytė Trakymienė10; Alice Trinchero11; Senthil Vel5 and Jan Astermark12;
MATERIALS AVAILABLE
Keywords